美国 · SEC FORM 4
IQVIA HOLDINGS INC.
IQV · NYSE · CIK 0001478242 · Healthcare · Diagnostics & Research
内部人信号
0 qualifying P purchase groups
当前 180 天评分窗口
18 同一窗口内观察到的 Form 4 交易行
9 sales · 9 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号?
评分构成
活跃窗口内没有合资格买入,因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数?
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示,不会形成负分。
卖出和其他 Form 4 活动会单独显示,不会形成负面买入信号。没有买入不会被评分为看空。
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后,这些模块才会启用。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型;卖出仅作为背景。
Showing the six most active owners; 4 additional owner(s) remain in Form 4 申报证据.
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2024-12-03 · DANHAKL JOHN G.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
空头余额是券商向 FINRA 申报的外部背景数据,不影响内部人信号。
- 空头股数
- 3,216,119
- 上期报告
- 4,116,522
- 日均成交量
- 1,845,306
- 回补天数
- 1.7
FINRA 结算日:2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数,每月两个结算日之后约一周公布;不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2024-12-03 | DANHAKL JOHN G | 买入 (P) | Common Stock | 1,275 | USD 200.58 | USD 255,740 | SEC 申报 ↗ |
| 2021-12-22 | DANHAKL JOHN G | 买入 (P) | Common Stock | 10,000 | USD 272.93 | USD 2,729,300 | SEC 申报 ↗ |
| 2021-09-23 | Bruehlman Ronald E | 买入 (P) | Common Stock | 4 | USD 262.82 | USD 1,051 | SEC 申报 ↗ |
| 2021-07-20 | Bruehlman Ronald E | 买入 (P) | Common Stock | 13 | USD 245.32 | USD 3,189 | SEC 申报 ↗ |
| 2020-12-23 | DANHAKL JOHN G | 买入 (P) | Common Stock | 63,451 | USD 176.95 | USD 11,227,654 | SEC 申报 ↗ |
| 2020-08-04 | Bruehlman Ronald E | 买入 (P) | Common Stock | 10,000 | USD 159.94 | USD 1,599,400 | SEC 申报 ↗ |
Form 4 申报证据
56 transaction lines in the latest 365-day window; 310 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-02 | Berkshire James G. | 卖出 (S) | Common Stock | 2,668 | USD 261.33 | USD 697,228 | SEC 申报 ↗ |
| 2026-09-02 | Berkshire James G. | 期权行权/转换 (M) | Common Stock | 5,381 | USD 131.82 | USD 709,323 | SEC 申报 ↗ |
| 2026-09-02 | Berkshire James G. | D (D) | Common Stock | 2,713 | USD 261.54 | USD 709,558 | SEC 申报 ↗ |
展开近期 Form 4 证据 (30 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-02 | Berkshire James G. | 卖出 (S) | Common Stock | 2,668 | USD 261.33 | USD 697,228 | SEC 申报 ↗ |
| 2026-09-02 | Berkshire James G. | 期权行权/转换 (M) | Common Stock | 5,381 | USD 131.82 | USD 709,323 | SEC 申报 ↗ |
| 2026-09-02 | Berkshire James G. | D (D) | Common Stock | 2,713 | USD 261.54 | USD 709,558 | SEC 申报 ↗ |
| 2026-08-03 | STAUB W RICHARD | 卖出 (S) | Common Stock | 5,500 | USD 232.68 | USD 1,279,740 | SEC 申报 ↗ |
| 2026-07-31 | Patel Bhavik | 卖出 (S) | Common Stock | 1,855 | USD 235.27 | USD 436,426 | SEC 申报 ↗ |
| 2026-07-29 | Sherbet Eric | 卖出 (S) | Common Stock | 5,000 | USD 249.16 | USD 1,245,800 | SEC 申报 ↗ |
| 2026-07-29 | Cherofsky Keriann | 卖出 (S) | Common Stock | 558 | USD 245.21 | USD 136,827 | SEC 申报 ↗ |
| 2026-07-29 | BOUSBIB ARI | 卖出 (S) | Common Stock | 106,279 | USD 245.51 | USD 26,092,072 | SEC 申报 ↗ |
| 2026-07-29 | BOUSBIB ARI | 期权行权/转换 (M) | Common Stock | 156,206 | USD 78.21 | USD 12,216,871 | SEC 申报 ↗ |
| 2026-07-29 | BOUSBIB ARI | D (D) | Common Stock | 49,927 | USD 244.70 | USD 12,217,110 | SEC 申报 ↗ |
| 2026-04-23 | LEONARD JOHN M | 奖励/授予 (A) | Common Stock | 1,571 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-04-23 | GOGGINS COLLEEN A | 奖励/授予 (A) | Common Stock | 1,571 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-04-23 | DANHAKL JOHN G | 奖励/授予 (A) | Common Stock | 1,571 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-04-23 | Burt Carol | 奖励/授予 (A) | Common Stock | 1,571 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-13 | Haas Bernd | 代扣税 (F) | Common Stock | 20 | USD 166.94 | USD 3,339 | SEC 申报 ↗ |
| 2026-02-13 | Fedock Michael J. | 代扣税 (F) | Common Stock | 123 | USD 166.94 | USD 20,534 | SEC 申报 ↗ |
| 2026-02-08 | Sherbet Eric | 代扣税 (F) | Common Stock | 1,915 | USD 187.49 | USD 359,043 | SEC 申报 ↗ |
| 2026-02-08 | Sherbet Eric | 奖励/授予 (A) | Common Stock | 6,806 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-08 | STAUB W RICHARD | 代扣税 (F) | Common Stock | 806 | USD 187.49 | USD 151,117 | SEC 申报 ↗ |
| 2026-02-08 | STAUB W RICHARD | 奖励/授予 (A) | Common Stock | 2,722 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-08 | Patel Bhavik | 代扣税 (F) | Common Stock | 1,920 | USD 187.49 | USD 359,981 | SEC 申报 ↗ |
| 2026-02-08 | Patel Bhavik | 奖励/授予 (A) | Common Stock | 4,083 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-08 | Haas Bernd | 代扣税 (F) | Common Stock | 440 | USD 187.49 | USD 82,496 | SEC 申报 ↗ |
| 2026-02-08 | Haas Bernd | 奖励/授予 (A) | Common Stock | 8,265 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-08 | Grenfell Alistair | 代扣税 (F) | Common Stock | 5,545 | USD 187.49 | USD 1,039,632 | SEC 申报 ↗ |
| 2026-02-08 | Grenfell Alistair | 奖励/授予 (A) | Common Stock | 11,795 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-08 | Fedock Michael J. | 代扣税 (F) | Common Stock | 2,420 | USD 187.49 | USD 453,726 | SEC 申报 ↗ |
| 2026-02-08 | Fedock Michael J. | 奖励/授予 (A) | Common Stock | 6,735 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-08 | Cherofsky Keriann | 代扣税 (F) | Common Stock | 415 | USD 187.49 | USD 77,808 | SEC 申报 ↗ |
| 2026-02-08 | Cherofsky Keriann | 奖励/授予 (A) | Common Stock | 1,087 | USD 0.00 | USD 0 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-19 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | IQV |
| CIK | 0001478242 |
| 行业 | Healthcare |
| 细分行业 | Diagnostics & Research Yahoo Finance |
| SEC SIC | 8731 Services-Commercial Physical & Biological Research |
| 交易所 | NYSE |
数据覆盖
| 本地 Form 4 历史 | 310 transaction lines from 2020-01-02 to 2026-09-02 6 P purchase lines · 66 S sale lines · 238 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-19. Mapping status is an audit field and does not erase SEC filing evidence.